Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
104,757
-
Share change
-
+89,753
-
Total reported value
-
$8,523,707
-
Price per share
-
$81.37
-
Number of holders
-
3
-
Value change
-
+$7,302,868
-
Number of buys
-
2
-
Number of sells
-
1
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2023
As of 31 Dec 2023,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
104,757 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, Avalon Trust Co, JPMORGAN CHASE & CO, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, Miller Investment Management, LP, Prime Capital Investment Advisors, LLC, BNP PARIBAS FINANCIAL MARKETS, and Independent Advisor Alliance.
This page lists
108
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.